RIMADYL® (carprofen) is the #1 veterinarian-recommended non-steroidal anti-inflammatory drug (NSAID) for pain relief for osteoarthritis, with more than 24 million dogs treated since 1996.1,2 In fact, more dogs have been treated with RIMADYL than all other NSAIDs combined.1

Expand All
    • The first FDA approved NSAID for dogs with osteoarthritis.

    • Backed by 20 years of research and science with more than 100 peer-reviewed articles confirming safety and efficacy.

    • #1 veterinarian-prescribed NSAID for dogs.1

    • Used to treat more than 24 million dogs with osteoarthritis.

    • Flexible once- or twice-daily dosing administered by the owner.

    • RIMADYL chewable is highly palatable and was readily accepted by >93% of dogs.2

    • Reliable quality and U.S.-based supply.

    • Given preoperatively to reduce postoperative pain.

    • Pre-emptive analgesic administered only by a veterinarian.

    • Encourages clients to sustain long-term care and return to your practice by giving them significant savings on products and services.

  • 1. Pet owners purchase RIMADYL at your clinic.

    2. They submit and upload invoices online to earn Rewards Points/Dollars.

    3. Clients use Rewards Dollars for RIMADYL and other products and services at your clinic.

    4. Visit to learn more.

  • As a class, NSAIDS may be associated with gastrointestinal, kidney and liver side effects. These are usually mild, but may be serious. Pet owners should discontinue therapy and contact their veterinarian immediately if side effects occur. Evaluation for pre-existing conditions and regular monitoring are recommended for pets on any medication, including RIMADYL. Use with other NSAIDS or corticosteroids should be avoided.

  • Reference

    1. VetInsight Analytics. January 2014.

    2. Payne-Johnson M, T. P. MAITLAND, J. BULLARD and J. GOSSELLIN Comparative palatability of three

    commercial formulations of carprofen and one commercial formulation of firocoxib in dogs. Revue Méd.

    Vét., 2006, 157, 8-9, 431-440.